Sarcoplasmic reticulum calcium mishandling: central tenet in heart failure?

Amanda L Denniss1, Alexander M Dashwood2,3, Peter Molenaar3,4

  • 1Centre for Research in Therapeutic Solutions and the Faculty of Science and Technology, University of Canberra, Bruce, ACT, 2617, Australia.

Biophysical Reviews
|July 23, 2020
PubMed

Insights

Altered calcium handling in the heart, specifically involving the sarcoplasmic reticulum (SR), leads to heart failure. Disruptions in calcium release (via RyR2) and reuptake (via SERCA2a) are key contributors.

Area of Science:

  • Cardiovascular Physiology
  • Molecular Cardiology
  • Biochemistry

Background:

  • Excitation-contraction coupling is vital for cardiac function, relying on calcium (Ca2+) cycling.
  • The sarcoplasmic reticulum (SR) regulates intracellular Ca2+ levels through release (ryanodine receptor, RyR2) and reuptake (SERCA2a pump).
  • Dysfunctional Ca2+ homeostasis in the SR is a hallmark of heart failure, causing impaired contractility and arrhythmias.

Purpose of the Study:

  • To review the molecular mechanisms of asynchronous Ca2+ cycling in the failing heart.
  • To highlight the role of SR Ca2+ handling in the pathogenesis of heart failure.

Main Methods:

  • Literature review focusing on molecular mechanisms of Ca2+ cycling.
  • Analysis of disruptions in RyR2 and SERCA2a regulatory pathways.

Main Results:

  • Asynchronous Ca2+ cycling around the SR contributes to heart failure.
  • Altered expression and regulatory pathways of RyR2 and SERCA2a are critical.

Conclusions:

  • SR Ca2+ dysregulation is central to heart failure development.
  • Targeting RyR2 and SERCA2a pathways may offer therapeutic strategies.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.5K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
557
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
593
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
1.5K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
248
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
361